CVE-2026-62194: OpenClaw versions before 2026.6.9 contain a privilege escalation vulnerability in the plugin install
Affects openclawSource GCVE Database
Not known to be exploited · CVSS 8.8 High : upgrade to 2026.6.9 soon.
Data as of 30 Oct 2026, 06:59 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 38% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 2026.6.9
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 14 Jul 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 29 Oct 2026.
What to do
Upgrade openclaw/openclaw to 2026.6.9.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
GitHubopenclaw/openclawpkg:github/openclaw/openclawOther threats | Affected
| Fixed in
|
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
If you cannot patch yet, restrict access to plugin installation features and review configurations to ensure input paths and features are not misconfigured or exposed to lower-trust users.
Description
OpenClaw versions before 2026.6.9 contain a privilege escalation vulnerability in the plugin install commands. This flaw allows lower-trust callers to execute or persist actions beyond their intended authorization by exploiting misconfigured input paths or enabled features. The vulnerability enables attackers to escalate privileges and perform unauthorized actions when the vulnerable feature is reachable.